[HTML][HTML] Comprehensive Overview of Molecular, Imaging, and Therapeutic Challenges in Rectal Mucinous Adenocarcinoma

M Berar, A Ciocan, E Moiș, L Furcea, C Popa… - International Journal of …, 2025 - mdpi.com
Rectal cancer is one of the most frequent malignancies worldwide. The most common
histological type is adenocarcinoma, followed by mucinous adenocarcinoma. The outcome …

CT and 3 Tesla MRI in the TN staging of colon cancer: a prospective, blind study

SR Rafaelsen, C Dam, C Vagn-Hansen, J Møller… - Current …, 2022 - mdpi.com
(1) Background: Computer tomography (CT) scanning is currently the standard method for
staging of colon cancer; however, the CT based preoperative local staging is far from …

Resistance to cell death in mucinous colorectal cancer—A review

E O'Connell, IS Reynolds, DA McNamara, JP Burke… - Cancers, 2021 - mdpi.com
Simple Summary Mucinous colorectal cancer is characterised by abundant mucin
glycoprotein production and is associated with resistance to chemotherapy-based …

Diffusion-weighted magnetic resonance imaging of mucin pools in locally advanced rectal mucinous adenocarcinoma predicts tumor response to neoadjuvant therapy

W Cao, B Li, J Gong, M Hu, W Li, X Pan… - European journal of …, 2020 - Elsevier
Purpose To determine the prognostic value of diffusion-weighted magnetic resonance
imaging (DW-MRI) of mucin pools (MPs) in predicting the response of patients with locally …

Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?

Y Ono, JMM Cates, RS Gonzalez - Pathology-Research and Practice, 2021 - Elsevier
Current standard therapy for locally advanced rectal cancer (LARC) is neoadjuvant therapy
followed by surgical resection; however, treatment response is variable among patients. This …

[PDF][PDF] 错配修复蛋白在直肠癌中的表达及其对新辅助放化疗敏感性的预测价值

程康文, 李佳, 王贵和, 束宽山, 郑明, 马冬花 - 中国普通外科杂志, 2020 - zpwz.net
摘要背景与目的: 术前新辅助放化疗(nCRT) 是治疗中低位局部进展期直肠癌的金标准,
完全病理缓解(pCR) 患者远期预后较好, 尽管有新的分子生物学发展和诊疗技术进步, 但对nCRT …

Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non …

M Ayhan, N Turan, O Köstek, G Tufan… - Current problems in …, 2021 - Elsevier
Purpose: To investigate the importance of mucinous histopathology on the assessment of
tumor response in patients with metastatic colorectal cancer (mCRC) receiving regorafenib …

[HTML][HTML] A Population-Based and Propensity Score-Matched Investigation of the Occurrence, Management, and Prognosis of Anal Mucinous Adenocarcinoma Patients

G Yao, Z Zhou, Y Wang, Y Jiang, J Wang… - Oncology Research …, 2024 - karger.com
Introduction: Anal mucinous adenocarcinoma (AMAC) is an extremely rare form of anal
cancer. Our objective was to examine the incidence, management, and prognostic factors of …

A New MRI-Defined Biomarker for Rectal Mucinous Adenocarcinoma: Mucin Pool Patterns in Determining the Efficacy of Neoadjuvant Therapy

W Cao, L Wu, Y Zhao, J Zhou, W Li, X Wang… - Frontiers in …, 2020 - frontiersin.org
Background and Aim: This work aims to study the relationship between MRI-defined mucin
pool (MP) patterns prior to treatment and the efficacy of neoadjuvant therapy (NAT) in locally …

[HTML][HTML] Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 …

DHW Liu, N Šefčovičová, J Emmerson… - European Journal of …, 2022 - Elsevier
Background Adenocarcinoma with more than 50% extracellular mucin is a relatively rare
histological subtype of gastrointestinal adenocarcinomas. The clinical impact of extracellular …